
How viruses can help the fight against antibiotic resistance
Phage therapies are currently used only in compassionate cases, where all antibiotics have failed and the patient's condition is critical. () Phage therapy uses viruses that specifically infect bacteria
India currently relies mostly on antibiotics for infections
AI helps identify and analyse over 1.3 million viral genomes
Antimicrobial resistance isn't just a silent pandemic â€' India bears one of the heaviest burdens globally.
While the country continues its search for new antibiotics to combat the crisis, researchers are now turning to naturally-occurring viruses in the environment as a promising tool to attack and kill multi-drug-resistant bacteria.
Karthik Anantharaman, a visiting professor at Wadhwani School of Data Science and AI at IIT Madras, is spearheading such a project in the US by studying the nature of viruses in their natural habitat to attack and kill bacteria, a process called phage therapy.
"One approach is to create more antibiotics but this only postpones the problem. New antibiotics also can lead to new forms of resistance, creating a never-ending cycle. An alternative and promising solution is phage therapy, which uses viruses called bacteriophages (or simply phages) to kill specific bacteria," Dr. Anantharaman, who is also a professor at the University of Wisconsin-Madison, told IndiaToday.in.
FINDING VIRUSES THAT KILL BACTERIA
Anantharaman and his team discovered that viruses have yearly cycles and can affect other organisms in the ecosystem.
As part of their study, some viruses were found to carry genes they had taken from the organisms they infected, which helped them carry out important biological functions.
The research team also put together over 1.3 million viral genomes â€' the largest collection of its kind so far. Lake Mendota in the US has been monitored consistently since the late 1800s (Photo: Center for Limnology, University of Wisconsin–Madison)
"In our lab, we are exploring how phages behave over time. We conducted a 20-year study of a single lake, using DNA sequencing and artificial intelligence (AI) to track how phage populations changed. By sequencing environmental DNA and using AI tools, we identified over 1.3 million viral genomes. This allowed us to see how viruses shift month to month, season to season, and year to year, and to predict their future behaviour," Dr. Anantharaman said.
While phage therapy might seem like a relatively new concept to Indian populations and even the West who rely heavily on antibiotics, Anantharaman mentioned that the phenomenon of using viruses to kill bacteria has been used in countries like Russia, Poland, Ukraine, and Georgia for decades.
VIRUSES AS ENVIRONMENTAL CLEANER
"Our goal is twofold: to improve human health and environmental health. Just as phages (virus) can target harmful bacteria in the human body, they can also be used to clean polluted ecosystems," University of Wisconsin-Madison professor said.
For example, if a lake turns black or emits a smell like rotten eggs, a sign of hydrogen sulfide produced by bacteria, phages can be used to selectively kill those bacteria and restore the lake's health. Anantharaman lab group at the University of Wisconsin-Madison, US, pictured by Lake Mendota.
Despite their promise, phage therapies are currently used only in compassionate cases, where all antibiotics have failed and the patient's condition is critical.
HOW DO PHAGES OR VIRUSES WORK AGAINST BACTERIA?
One major reason phages haven't entered mainstream treatment is that researchers still don't fully understand how they evolve over time.
Consequently, there are no approved phage-based therapeutic products in India, the US, or Europe.
But phages hold great promise, especially when used in combination with antibiotics.
Here's how it works: when bacteria face antibiotics, they come under stress. Sometimes, this stress causes genetic changes that make them resistant.
But in that process, bacteria may also become vulnerable to phages. So, using both antibiotics and phages together creates a powerful, complementary treatment strategy.
In some cases, antibiotics work where phages don't and vice versa. Anantharaman lab member Patricia Tran sampling Lake Mendota, US. over frozen ice in the Winter.
"One major advantage of phages is their precision. Unlike antibiotics, which kill both harmful and beneficial bacteria, phages target only one specific strain. If a person is infected with Pseudomonas, the phage used will kill only Pseudomonas, sparing the rest of the body's microbiome. That's a game-changer for preserving overall health during treatment," Anantharaman explained.
Another surprising fact is that viruses are everywhere - even inside us.
There are 10 to 100 times more viral particles in and on our bodies than human cells.
These include many harmless phages that silently regulate bacterial populations. Phages are found in lakes, rivers, soil, oceans, and even in our intestines and on our skin. Anantharaman lab member Dinesh Kumar Kuppa Baskaran sampling Lake Mendota in the Summer.
"In our lab, we use AI â€' both machine learning and deep learning â€' to rapidly identify phages from environmental samples. This process, which used to take years, now takes just a day. AI allows us to sift through millions of DNA sequences and pinpoint the viruses that can infect specific harmful bacteria," Anantharaman said.
BARRIERS PERSIST
However, awareness remains a major barrier.
The medical community and industry are still focused on antibiotics. There's limited investment in phage therapy, and the necessary research infrastructure hasn't yet been built.
For phage therapy to move forward, government support and academic research are essential.
"Industry isn't currently interested in developing phage-based treatments â€' it's mostly up to institutions and public funding. But as the threat of antibiotic resistance grows, this is expected to change," Anantharaman opined.
Phage therapy isn't just a scientific curiosity. It could be a major pillar of future medicine â€' if we choose to invest in it.
Antimicrobial resistance isn't just a silent pandemic â€' India bears one of the heaviest burdens globally.
While the country continues its search for new antibiotics to combat the crisis, researchers are now turning to naturally-occurring viruses in the environment as a promising tool to attack and kill multi-drug-resistant bacteria.
Karthik Anantharaman, a visiting professor at Wadhwani School of Data Science and AI at IIT Madras, is spearheading such a project in the US by studying the nature of viruses in their natural habitat to attack and kill bacteria, a process called phage therapy.
"One approach is to create more antibiotics but this only postpones the problem. New antibiotics also can lead to new forms of resistance, creating a never-ending cycle. An alternative and promising solution is phage therapy, which uses viruses called bacteriophages (or simply phages) to kill specific bacteria," Dr. Anantharaman, who is also a professor at the University of Wisconsin-Madison, told IndiaToday.in.
FINDING VIRUSES THAT KILL BACTERIA
Anantharaman and his team discovered that viruses have yearly cycles and can affect other organisms in the ecosystem.
As part of their study, some viruses were found to carry genes they had taken from the organisms they infected, which helped them carry out important biological functions.
The research team also put together over 1.3 million viral genomes â€' the largest collection of its kind so far. Lake Mendota in the US has been monitored consistently since the late 1800s (Photo: Center for Limnology, University of Wisconsin–Madison)
"In our lab, we are exploring how phages behave over time. We conducted a 20-year study of a single lake, using DNA sequencing and artificial intelligence (AI) to track how phage populations changed. By sequencing environmental DNA and using AI tools, we identified over 1.3 million viral genomes. This allowed us to see how viruses shift month to month, season to season, and year to year, and to predict their future behaviour," Dr. Anantharaman said.
While phage therapy might seem like a relatively new concept to Indian populations and even the West who rely heavily on antibiotics, Anantharaman mentioned that the phenomenon of using viruses to kill bacteria has been used in countries like Russia, Poland, Ukraine, and Georgia for decades.
VIRUSES AS ENVIRONMENTAL CLEANER
"Our goal is twofold: to improve human health and environmental health. Just as phages (virus) can target harmful bacteria in the human body, they can also be used to clean polluted ecosystems," University of Wisconsin-Madison professor said.
For example, if a lake turns black or emits a smell like rotten eggs, a sign of hydrogen sulfide produced by bacteria, phages can be used to selectively kill those bacteria and restore the lake's health. Anantharaman lab group at the University of Wisconsin-Madison, US, pictured by Lake Mendota.
Despite their promise, phage therapies are currently used only in compassionate cases, where all antibiotics have failed and the patient's condition is critical.
HOW DO PHAGES OR VIRUSES WORK AGAINST BACTERIA?
One major reason phages haven't entered mainstream treatment is that researchers still don't fully understand how they evolve over time.
Consequently, there are no approved phage-based therapeutic products in India, the US, or Europe.
But phages hold great promise, especially when used in combination with antibiotics.
Here's how it works: when bacteria face antibiotics, they come under stress. Sometimes, this stress causes genetic changes that make them resistant.
But in that process, bacteria may also become vulnerable to phages. So, using both antibiotics and phages together creates a powerful, complementary treatment strategy.
In some cases, antibiotics work where phages don't and vice versa. Anantharaman lab member Patricia Tran sampling Lake Mendota, US. over frozen ice in the Winter.
"One major advantage of phages is their precision. Unlike antibiotics, which kill both harmful and beneficial bacteria, phages target only one specific strain. If a person is infected with Pseudomonas, the phage used will kill only Pseudomonas, sparing the rest of the body's microbiome. That's a game-changer for preserving overall health during treatment," Anantharaman explained.
Another surprising fact is that viruses are everywhere - even inside us.
There are 10 to 100 times more viral particles in and on our bodies than human cells.
These include many harmless phages that silently regulate bacterial populations. Phages are found in lakes, rivers, soil, oceans, and even in our intestines and on our skin. Anantharaman lab member Dinesh Kumar Kuppa Baskaran sampling Lake Mendota in the Summer.
"In our lab, we use AI â€' both machine learning and deep learning â€' to rapidly identify phages from environmental samples. This process, which used to take years, now takes just a day. AI allows us to sift through millions of DNA sequences and pinpoint the viruses that can infect specific harmful bacteria," Anantharaman said.
BARRIERS PERSIST
However, awareness remains a major barrier.
The medical community and industry are still focused on antibiotics. There's limited investment in phage therapy, and the necessary research infrastructure hasn't yet been built.
For phage therapy to move forward, government support and academic research are essential.
"Industry isn't currently interested in developing phage-based treatments â€' it's mostly up to institutions and public funding. But as the threat of antibiotic resistance grows, this is expected to change," Anantharaman opined.
Phage therapy isn't just a scientific curiosity. It could be a major pillar of future medicine â€' if we choose to invest in it. Join our WhatsApp Channel
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Print
16 minutes ago
- The Print
SRAM & MRAM Group Celebrates 30 Glorious Years; Announces USD500 Million Indo-Kazakh Medical Project in London
New Delhi [India], June 14: SRAM & MRAM Group, a global conglomerate with interests across fintech, healthcare, AI, agriculture, biotechnology, and more, proudly marked its 30th anniversary with a grand international celebration in London. On this momentous occasion, the Group announced the signing of a landmark USD 500 million contract between India's Mont Vert Group and Kazakhstan's Big B Corporation to build a state-of-the-art Medical University and Hospital in Kazakhstan. This landmark deal signals SRAM & MRAM Group's growing commitment to global healthcare and education infrastructure. Driving the Vision: Ajay Bhandari and Mahendra Joshi Lead the Charge The agreement was made possible through the efforts of Mr. Ajay Bhandari, Director, Big B Corporation, and Mr. Mahendra Joshi, Director, SRAM & MRAM Group. Their leadership, international collaboration, and strategic insight were key in structuring and executing the project. They were ably supported by Mr. Nitin Gupta, Director, SRAM & MRAM India, who helped align all stakeholders and facilitate the successful closure of the deal. Mont Vert Group: A Legacy of Trust and Quality from Pune The construction and development responsibilities have been entrusted to Mont Vert Group; one of Pune's most reputed and trusted real estate developers. Mr. Jayant Kaneria, Chairman, and Mr. Neeraj Kaneria, Managing Director, bring over three decades of industry experience with a portfolio exceeding 6.8 million sq. ft. of delivered residential and commercial projects. SRAM & MRAM Group expressed deep pride in partnering with Mont Vert Group, acknowledging their longstanding commitment to quality, transparency, and timely delivery. 'Mont Vert Group represents the highest standards of Indian real estate leadership,' said Dr. Sailesh Lachu Hiranandani, Chairman, SRAM & MRAM Group. 'Their proven track record and commitment to excellence make them an ideal partner for this international healthcare initiative.' Event Highlights and Attendees The announcement was made during SRAM & MRAM's anniversary celebration on Raven's Ait Private Island, London, in the presence of esteemed dignitaries and global business leaders. Key dignitaries included: – Mr. Jayant Kaneria, Chairman, Mont Vert Group – Mr. Neeraj Kaneria, Managing Director, Mont Vert Group – Mr. Ajay Bhandari, Director, Big B Corporation (Kazakhstan) – Mr. Mahendra Joshi, Director, SRAM & MRAM Group – Mr. Nitin Gupta, Director, SRAM & MRAM – Dr. Swapnil Kamble, Director, SRAM & MRAM India 'As we celebrate three decades of transformative work across sectors, this partnership marks a new chapter in our journey,' said Dr. Hiranandani. 'With this project, we reinforce our commitment to driving positive change globally through healthcare, innovation, and collaborative growth.' Founded in 1995, SRAM & MRAM Group is a global enterprise headquartered in London, with operations in over 60 countries. The group works across sectors including fintech, AI, healthcare, agriculture, mining, biotechnology, and semiconductors, and continues to drive large-scale global projects with impact. (ADVERTORIAL DISCLAIMER: The above press release has been provided by NewsVoir. ANI will not be responsible in any way for the content of the same) This story is auto-generated from a syndicated feed. ThePrint holds no responsibility for its content.


The Print
32 minutes ago
- The Print
Operation Sindoor showed operational capability of India's armed forces: Raha
Stating the success of Brahmos supersonic missiles makes him 'very proud,' Raha, now Chancellor of Assam University, recalled that the project had begun years back. Operation Sindoor demonstrated the tremendous potential the country has gained over the years, he said at a conference organised by the Indian Chamber of Commerce on the role of MSME in the defence sector. Kolkata, Jun 14 (PTI) Former Chief of Air Staff, Air Chief Marshal (Retd) Arup Raha, on Saturday said the Operation Sindoor against terror bases in Pakistan after the Pahalgam attack showed the true operational capability of India's armed forces. 'India achieved a tremendous landmark. ISRO has become the leading organisation in the world in space research. From lunar to solar projects, ISRO is setting one goal after another. Under ISRO's guidance, we have developed a powerful rocket system. Our satellites are… used by other countries which are not strong economically. ISRO is meeting various requirements in different fields,' he said. Raha said satellites were also put in orbit by ISRO to strengthen defence operations. 'Command and control data, gleaned by satellites, are being processed using Artificial Intelligence and helping in surveillance, to keep track of borders, for dynamic targeting across borders during Operation Sindoor,' he said. In Operation Sindoor, Indian armed forces in the early hours of May 7 carried out missile strikes on nine terror targets in Pakistan and Pakistan-occupied Kashmir (PoK), including the Jaish-e-Mohammad stronghold of Bahawalpur and Lashkar-e-Taiba's base Muridke. The operation was retaliation to the April 22 terror attack, in which 26 people, mostly tourists, were killed in Jammu and Kashmir's Pahalgam. In his speech, Raha said the missiles developed by DRDO are packed with 5 to 10 times the speed of sound through space. He said projects like the Light Combat Aircraft (LCA) and integrated command control project have taken India to the front-running nations, in the sectors of IT, ITes, space, efficient propulsion systems, ships, submarines, nanotechnologies, AI and robotics. Raha, however, added that there is one problem area, as India is not good at making jet jet propulsion engines. 'We are buying engines from Americans…..this dependency is not good. We are losing our strategic autonomy by importing state-of-the-art technologies which incur lots of expenses,' he said. The country needs to think about this in the next 10 years in terms of employment generation and export revenues, Raha said. 'Larger players both in public and private sectors need to build up a supply chain, a self-supporting ecosystem of building our capabilities and developing capability in the defence sector, in developing our capability in civil aviation,' he said. If hundreds of aircraft are bought from global aviation majors, billions of dollars would fly out of the country, the former Air Force officer said. 'Why pay money to outsiders? We need to have a combined plan and a strategic plan in the air sector,' he said. Raha advocated setting up a defence corridor and taking MSMEs of the eastern region to the defence hub elsewhere in the country. PTI SUS NN This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.


Business Standard
an hour ago
- Business Standard
SRAM & MRAM Group Celebrates 30 Glorious Years; Announces USD500 Million Indo-Kazakh Medical Project in London
NewsVoir New Delhi [India], June 14: SRAM & MRAM Group, a global conglomerate with interests across fintech, healthcare, AI, agriculture, biotechnology, and more, proudly marked its 30th anniversary with a grand international celebration in London. On this momentous occasion, the Group announced the signing of a landmark USD 500 million contract between India's Mont Vert Group and Kazakhstan's Big B Corporation to build a state-of-the-art Medical University and Hospital in Kazakhstan. This landmark deal signals SRAM & MRAM Group's growing commitment to global healthcare and education infrastructure. Driving the Vision: Ajay Bhandari and Mahendra Joshi Lead the Charge The agreement was made possible through the efforts of Mr. Ajay Bhandari, Director, Big B Corporation, and Mr. Mahendra Joshi, Director, SRAM & MRAM Group. Their leadership, international collaboration, and strategic insight were key in structuring and executing the project. They were ably supported by Mr. Nitin Gupta, Director, SRAM & MRAM India, who helped align all stakeholders and facilitate the successful closure of the deal. Mont Vert Group: A Legacy of Trust and Quality from Pune The construction and development responsibilities have been entrusted to Mont Vert Group; one of Pune's most reputed and trusted real estate developers. Mr. Jayant Kaneria, Chairman, and Mr. Neeraj Kaneria, Managing Director, bring over three decades of industry experience with a portfolio exceeding 6.8 million sq. ft. of delivered residential and commercial projects. SRAM & MRAM Group expressed deep pride in partnering with Mont Vert Group, acknowledging their longstanding commitment to quality, transparency, and timely delivery. "Mont Vert Group represents the highest standards of Indian real estate leadership," said Dr. Sailesh Lachu Hiranandani, Chairman, SRAM & MRAM Group. "Their proven track record and commitment to excellence make them an ideal partner for this international healthcare initiative." Event Highlights and Attendees The announcement was made during SRAM & MRAM's anniversary celebration on Raven's Ait Private Island, London, in the presence of esteemed dignitaries and global business leaders. Key dignitaries included: - Mr. Jayant Kaneria, Chairman, Mont Vert Group - Mr. Neeraj Kaneria, Managing Director, Mont Vert Group - Mr. Ajay Bhandari, Director, Big B Corporation (Kazakhstan) - Mr. Mahendra Joshi, Director, SRAM & MRAM Group - Mr. Nitin Gupta, Director, SRAM & MRAM - Dr. Swapnil Kamble, Director, SRAM & MRAM India "As we celebrate three decades of transformative work across sectors, this partnership marks a new chapter in our journey," said Dr. Hiranandani. "With this project, we reinforce our commitment to driving positive change globally through healthcare, innovation, and collaborative growth." Founded in 1995, SRAM & MRAM Group is a global enterprise headquartered in London, with operations in over 60 countries. The group works across sectors including fintech, AI, healthcare, agriculture, mining, biotechnology, and semiconductors, and continues to drive large-scale global projects with impact.